Lung Cancer

MDT critical to best outcomes in stage lll NSCLC

The lung cancer multidisciplinary team (MDT) is critical to best practice and better outcomes in patients with stage lll non-small cell lung cancer (NSCLC). However, according to a review article in the Asia-Pacific Journal of Clinical Oncology, only about half of patients are receiving this level of care in Australia. “Patients with stage III NSCLC ...

Already a member?

Login to keep reading.

© 2022 the limbic